NCT01546740UnknownNot Applicable
Glaucoma Prevalence in the Israeli Arab Population
Ziv Hospital1 site in 1 country15,000 target enrollmentStarted: January 2012Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 15,000
- Locations
- 1
Study Overview
Brief Summary
there is a variety of glaucoma prevalence within different populations. this study examine the prevalence of glaucoma in the Arab population in Israel' as well as the demographic variables and the compliance to treatment in the population.
Detailed Description
from Medical records of primary care clinic in the city of Tira. the patients are recruited, all glaucoma patients are above age of 20 years. they must suffer from CDR >= 0.5 with/without asymmetry with the other eye. or they suffer from glaucomatous damage to the visual fields.
Study Design
- Study Type
- Observational
- Observational Model
- Ecologic Or Community
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 20 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Cup-to-disk ratio (CDR) > 0.5 with asymmetry between the eyes
- •Intraocular pressure (IOP) > 23 mm Hg
- •Damage to the field of vision
- •Age- above 20 Yrs. old
Exclusion Criteria
- Not provided
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Prevalence of Ocular Surface Disease in Glaucoma PatientsGlaucomaNCT00382122Alcon Research101
Unknown
Not Applicable
Incidence and Progression of Glaucoma in the Tema Eye Survey CohortGlaucomaNCT02085850Tema Christian Eye Center1,375
Unknown
Not Applicable
Patterns of Glaucoma in Glaucoma Subspecialty Clinics in Egypt and India in the Year 2018Determining Patterns of Glaucoma in Glaucoma Sub-specialty Clinics in Two Countries: Egypt and IndiaNCT03491735Kasr El Aini Hospital2,500
Completed
Not Applicable
Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular HypertensionRetinaOcular PhysiologyNCT00706927Medical University of Vienna16
Active, not recruiting
Phase 3
Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle GlaucomaOpen-Angle GlaucomaNCT05411198AbbVie65
